Results 251 to 260 of about 2,113,177 (314)

Functional and Structural Evidence of Neurofluid Circuit Aberrations in Huntington Disease

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Disrupted neurofluid regulation may contribute to neurodegeneration in Huntington disease (HD). Because neurofluid pathways influence waste clearance, inflammation, and the distribution of central nervous system (CNS)–delivered therapeutics, understanding their dysfunction is increasingly important as targeted treatments emerge.
Kilian Hett, Abigail Dubois, Melanie Leguizamon, Alexander Song, Paula Trujillo, Colin D. McKnight, Ciaran M. Considine, Manus J. Donahue, Daniel O. Claassen   +8 more
wiley   +1 more source

Autophagy Modulates Immunogenic Cell Death in Cancer. [PDF]

Cancers (Basel)
Matsushita M, Moriwaki M.
europepmc   +1 more source

Air Pollution and the Risk and Progression of Multiple Sclerosis: A Systematic Review and Meta‐Analysis

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Purpose Air pollution has been linked to several neurological conditions, including stroke and neurodegenerative diseases. Evidence regarding its association with multiple sclerosis (MS) remains conflicting, limited by small sample sizes. Methods PubMed, Embase, Scopus, and Cochrane controlled register of trials (CENTRAL) were searched on ...
Ahmad A. Toubasi, Thuraya N. Al‐Sayegh
wiley   +1 more source

Editorial: Role of ncRNAs in immunogenic cell death of cancer. [PDF]

Front Immunol
Zhuo S, Zhu T, Zhao N, Peng F, Zhu X, Wang Z, Wang N.   +6 more
europepmc   +1 more source

Developmental and Epileptic Encephalopathy due to Biallelic Pathogenic Variants in PIGM

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective PIGM encodes a critical enzyme in the glycosylphosphatidylinositol (GPI)‐anchor biosynthesis pathway. While promoter‐region mutations in PIGM have been associated with a relatively mild phenotype characterized by portal vein thrombosis and absence seizures, recent evidence suggests that coding‐region mutations result in a more severe
Júlia Sala‐Coromina, Anna Marcé‐Grau, Barbara Masotto, Marta Codina, Lamia BenJemaa, Yasmina Elaribi, Mónica Martinez‐Gallo, Roger Colobran, Angel Sanchez‐Montañez, Irene Valenzuela, Yoshiko Murakami, Alfons Macaya   +11 more
wiley   +1 more source

Programmed cell death in cancer: targeting necroptosis to kill tumor cell. [PDF]

Cell Death Discov
Liang J, Tan C, Li X, Fan J, Liu B.
europepmc   +1 more source

Oncolytic Virotherapy and Immunogenic Cell Death: Mechanisms, Platforms, and Clinical Translation. [PDF]

Viruses
Inoue H.
europepmc   +1 more source

MAP4Ks drive cell death in response to <i>Salmonella</i> SpvB-induced actin depolymerization. [PDF]

mBio
Pallett MA, Tocci R, Majstorovic A, Everatt E, Panagi I, Diaz-Del-Olmo I, Godlee C, Thurston TLM, Holden DW.   +8 more
europepmc   +1 more source

PRRSV subverts host programmed cell death network for immune evasion. [PDF]

Virulence
Ma S, Mao Q, Weng S, Lian K, Jiang Z, Hao J, Zhang K.   +6 more
europepmc   +1 more source

A cell death program-based tumor signature stratifies prognosis, immune landscape, and therapeutic response in glioma. [PDF]

Front Oncol
Zhang H, Yang Z, Xie Q, Chen P, Huang J, Liu S, Li Z, Sun W, Zhang X, Xie T.   +9 more
europepmc   +1 more source